RISKS VERSUS BENEFITS IN ANTISCHISTOSOMAL THERAPY
1969; Wiley; Volume: 160; Issue: 2 Linguagem: Inglês
10.1111/j.1749-6632.1969.tb15902.x
ISSN1749-6632
Autores Tópico(s)Therapeutic Uses of Natural Elements
ResumoAnnals of the New York Academy of SciencesVolume 160, Issue 2 p. 811-820 RISKS VERSUS BENEFITS IN ANTISCHISTOSOMAL THERAPY F. Fontanilles, F. Fontanilles Medical Department, Pharmaceutical Division CIBA Limited, Basle, SwitzerlandSearch for more papers by this author F. Fontanilles, F. Fontanilles Medical Department, Pharmaceutical Division CIBA Limited, Basle, SwitzerlandSearch for more papers by this author First published: October 1969 https://doi.org/10.1111/j.1749-6632.1969.tb15902.xCitations: 13AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 LAMBERT, C. R. & F. S. DA CRUZ FERREIRA. 1965. Résultats du premier essai de traitement de la bilharziose vésicale par le CIBA 32,644-Ba. Bull. WHO 32: 73– 82. 2 LARIVIÈRE, M., P. CAMERLYNCK, M. REY. 1965. Action du CIBA 32,644-Ba sur les bilharzioses a S. haematobium et S. mansoni. Presse Med. 73: 2842. 3 LUCAS, A. O., W. P. COCKSHOTT, C. C. ADENIYI-JONES & H. M. GILLES. 1966. Radiological changes after medical treatment of vesical schistosomiasis. Lancet II: 631– 633. 4 HUGONOT, R. & S. DELONS. 1966. Étude clinique au Maroc du CIBA 32,644-Ba. (Amibiase et Bilharziose). Acta Trop. Suppl. 9: 110– 119. 5 DAVIS, A. 1966. Effect of CIBA 32,644-Ba on Schistosoma haematobium. Acta Trop. Suppl. 9: 132– 144. 6 BLAIR, D. & V. DE V. CLARKE. 1966. Field trials with CIBA 32,644-Ba in Rhodesia. Acta Trop. Suppl. 9: 145– 151. 7 DODIN, A., E. R. BRYGOO, C. R. LAMBERT, RATOVONDRAHETY & J. P. MOREAU. Activité du CIBA 32,644-Ba sur l'élimination des oeufs de Schistosoma mansoni et Schistosoma haematobium. Bull. Soc. Path. Exot. 58: 462– 471 (1965); Acta Trop. Suppl. 9: 168–176 (1966); Presse Med. 73: 2696 (1965). 8 DUCASSE, B. 1966. Premier résultats obtenus dans le traitement des bilharzioses humaines à S. haematobium et S. mansoni avec le CIBA 32,644-Ba. Acta Trop. Suppl. 9: 196– 202. 9 RUAS, A. & L. T. A. FRANCO. 1966. 1000 cas d'infestation à S. haematobium et S. mansoni traités selon différents schemas par le CIBA 32,644-Ba. Recherche d'activité et des effets secondaires. Acta Trop. Suppl. 9: 203– 207. 10 ARFAA, F., I. FARAHMANDIAN & H. BIJAN. 1966. Trial of CIBA 32,644-Ba in the mass-treatment of urinary bilharziasis. Acta Trop. Suppl. 9. 11 GAILLARD, M. 1966. Premiers résultats du traitement de la bilharziose vésicale et intestinale en Casamance par le CIBA 32,644-Ba. Acta Trop. Suppl. 9: 219– 233. 12 GENTILINI, M., A. CAPRON, J. -C. IMBERT, J.-P. ESCANDE, A. VERNES & A. DOMART. Essais thérapeutiques d'un dérivé du nitrothiazole, le CIBA 32,644-Ba, dans la bilharziose chronique. Etude clinique et sérologique portant sur 100 malades. Presse Med. 74: 890. 13 ABDALLAH, A., M. SAIF, M ABDEL-MEGUID, A. BADRAN, F. ABDEL-FATTAH, I. M. ALY. 1966. Treatment of urinary and intestinal bilharziasis with CIBA 32,644-Ba (Ambilhar). A preliminary report. J. Egypt. Med. Ass. 49: 145– 163. 14 CLARKE, V. DE V. & D. M. BLAIR. 1966. Trials with Ambilhar (CIBA 32,644-Ba) in the treatment of bilharziasis in Rhodesia. Cent. Afr. J. Med. 12: 64– 68. 15 SHERIF, A. F., S. A. HADARY, R. M. BARAKAT, M. M. ABDEL-FATTAH & H. MORCOS. 1966. Clinical trials on the antibilharzial effect of a new nitrothiazole compound. J. Egypt. Public Health Ass. 41: 47– 66. 16 POWELL, S. J. & I. N. MACLEOD. 1966. Ambilhar, a nitrothiazole derivative, in urinary tract bilharzia. S. Afr. Med. J. 40: 881. 17 RAFFIER, G. & R. KONAN KOUASSI. 1966. Etude de l'activité du produit CIBA 32,644-Ba dans la bilharziose vésicale. Afr. Med. 5: 441– 445. 18 LAVARDE-LOT, V. 1966. A propos de 204 bilharziens urinaires chroniques traités par le nitrothiamidazole (CIBA 32,644-Ba). (Résultats cliniques, parasitologiques, endoscopiques et radiologiques). Thesis. University of Paris, Paris, France. 70 pp. 19 RUAS, A. & L. T. A. FRANCO. 1966. The effect of CIBA 32,644-Ba in the treatment of 1,059 cases of vesical and intestinal schistosomiasis. Ann. Trop. Med. Parasit. 60: 288– 292. 20 WOLFE, H. L. 1967. Treatment of urinary schistosomiasis with niridazole (Ambilhar) in 576 African schoolchildren. Lancet II: 350– 354. 21 SALIBA, G. 1966. Contribution à l'étude au Maroc des lésions bilharziennes à Schistosoma haematobium sous l'angle séméiologique, évolutif et thérapeutique. Thesis. University of Lyons. Lyons, France. 158 pp. 22 DAVIS, A. 1966. Field trials of Ambilhar in the treatment of urinary bilharziasis in schoolchildren. Bull. WHO 35: 827– 835. 23 SANKALÉ, M., R. BAYLET, M. MOULANIER, J. GIUDICELLI, R. AURY & A. BOURGEADE. 1967. Le traitement de la bilharziose. A propos de 65 malades traités à Dakar par le niridazole. Presse Med. 75: 1401– 1404. 24 DODIN, A., J. P. MOREAU & RATOVONDRAHETY. 1966. Perspective d'avenir en ce qui concerne le traitement et la prophylaxie de la bilharziose. Bull. Soc. Path. Exot. 59: 106– 109. 25 JORDAN, P. 1966. Trial of Ambilhar, a nitrothiazole derivative, in S. mansoni infections in Tanzania. Brit. Med. J. 2: 276– 278. 26 ARGENTO, C. A., P. F. NEVES, F. A. G. PEREIRA & J. R. DA SILVA. 1965. O composto CIBA 32,644-Ba (adminonitrotiazol) no tratamento da esquistossomose mansoni. Nota prévia. Folha Med. 51: 471– 479. 27 PRATA, A. 1966. Resultados complementares sôbre a eficiência do nôvo nitrotiazol (CIBA 32,644-Ba) na esquistossomose mansoni. Hospital 69: 175– 177. 28 DA SILVA, J. R. 1966. A clinical trial of CIBA 32,644-Ba in Schistosomiasis mansoni. Acta Trop. Suppl. 9: 177– 179. 29 PRATA, A., R. MACHADO & V. MACEDO. 1966. Treatment of Schistosomiasis mansoni with a new nitrothiazole derivative, CIBA 32,644-Ba. Acta Trop. Suppl. 9: 180– 186. 30 COUTINHO, A., C. A. LIMA & C. ALVES. 1966. A clinical trial of CIBA 32,644-Ba in patients with S. mansoni bilharziasis. Acta Trop. Suppl. 9: 187– 195. 31 COUTINHO, A., C. A. LIMA & C. ALVES. 1966. Clinical trials with CIBA 32,644-Ba (nitrothiazole compound) in mansoni schistosomiasis. Rev. Inst. Med. Trop. Säo Paulo 8: 89– 98. 32 McMAHON, J. E. & C. P. KILALA. 1966. Clinical trial with Ambilhar in Schistosoma mansoni infections in Tanzania. Brit. Med. J. 2: 1047– 1049. 33 NOHMI, N., P. N. REZENDE, G. MAGELA & J. LOPES. 1966. Terapêutica com o CIBA 32,644-Ba. Tratamento da esquistossomose mansoni. Rev. Brasil Med. 23: 433– 440. 34 PELLEGRINO, J. 1966. Mesa-redonda sôbre o CIBA 32,644-Ba (Ambilhar). Folha Med. 53: 27– 34. 35 KATZ, N. 1966. Mesa-redonda sôbre o CIBA 32,644-Ba (Ambilhar). Folha Med. 53: 34– 37. 36 NEVES, J. 1966. Mesa-redonda sôbre o CIBA 32,644-Ba (Ambilhar). Folha Med. 53: 37– 48. 37 DA CUNHA, A. S. 1966. Mesa-redonda sôbre o CIBA 32,644-Ba (Ambilhar). Folha Med. 53: 48– 74. 38 NOHMI, N. 1966. Mesa-redonda sôbre o CIBA 32,644-Ba (Ambilhar). Folha Med. 53: 72– 79. 39 BITTENCOURT, C. 1966. Mesa-redonda sôbre o CIBA 32,644-Ba (Ambilhar). Folha Med. 53: 79– 81. 40 MARQUES, R. J. 1966. Mesa-redonda sôbre o CIBA 32,644-Ba (Ambilhar). Folha Med. 53: 81– 89. 41 COUTINHO, A. 1966. Mesa-redonda sôbre o CIBA 32,644-Ba (Ambilhar). Folha Med. 53: 89– 95. 42 TEIXEIRA, R. 1966. Mesa-redonda sôbre o CIBA 32,644-Ba (Ambilhar). Folha Med. 53: 95– 99. 43 BARANSKI, M. 1966. Mesa-redonda sôbre o CIBA 32,644-Ba (Ambilhar). Folha Med. 53: 101– 110. 44 DA SILVA, L. C. 1966. Mesa-redonda sôbre o CIBA 32,644-Ba (Ambilhar). Folha Med. 53: 111– 112. 45 CAMPOS, R. 1966. Mesa-redonda sôbre o CIBA 32,644-Ba (Ambilhar). Folha Med. 53: 112– 115. 46 MAGALDI, C. 1966. Mesa-redonda sôbre o CIBA 32,644-Ba (Ambilhar). Folha Med. 53: 115– 116. 47 GALVAO, F. 1966. Mesa-redonda sôbre o CIBA 32,644-Ba (Ambilhar). Folha Med. 53: 116– 125. 48 KLOETZEL, K. 1966. Mesa-redonda sôbre o CIBA 32,644-Ba (Ambilhar). Folha Med. 53: 125– 126. 49 SCHERB, J., E. LOPES & P. BORBA. 1966. Efeitos colaterais imediato do aminonitrotiazol no tratamento de esquistossomose mansônica. Especial referência ás manifestações neuropsíquicas e eletroencefalográficas. Folha Med. 53: 627– 644. 50 KATZ, N., D. BITTENCOURT, C. A. OLIVEIRA, R. P. DIAS, H. FERREIRA, E. GRINBAUM, C. B. DIAS & J. PELLEGRINO. 1966. Clinical trials with CIBA 32,644-Ba (Ambilhar) in Schistosomiasis mansoni. Folha Med. 53: 561– 567. 51 PESSOA, A. V., S. B. BROCHADO, J. R. DA SILVA, D. OLIVEIRA & O. LAVIGNE DE SOUZA. 1967. Tratamento da esquistossomose mansonica com o ambilhar. Rev. Brasil Med. 24: 28– 29. 52 LEITE, J. F. 1966. Tratamento da esquistossomose mansoni pelo CIBA 32,644-Ba. Rev. Brasil Med. 23: No. 11. 53 DODIN, A. & J. P. MOREAU. 1967. Résultat des essais de protection de l'homme contre la réinfestation bilharzienne au moyen de cercaires inactivées. C. R. Acad. Sci. (Paris) 264: 1538– 1540. 54 DE OLIVEIRA, P. A. & G. DA S. TRIGUEIRO. 1966. Observações sôbre o emprêgo do CIBA 32,644-Ba no tratamento da esquistossomose mansônica em zona endêmica. Rev. Brasil Med. 23: 12. 55 MCMAHON, J. E. 1967. Ambilhar in the treatment of schistosoma mansoni infections in schoolchildren. E. Afr. Med. J. 44: 209– 214. 55a BLAIR, D. M. & V. DE V. CLARKE. Unpublished report. 56 YOKOGAWA, M., M. TSUJI, K. ARAKI, T. IIJIMA, Y. ITO, T. SASAKI & M. TSUJI. 1966. Preliminary report of clinical observations on the treatment of schistosomiasis japonica with the nitrothiazole derivative CIBA 32,644-Ba. Acta Trop. Suppl. 9: 244– 255. 57 YOKOGAWA, M. 1967. Personal communication. 58 LIBORO, O. L., F. M. PINEDA & M. G. YOGORE, JR. 1966. Preliminary report: Treatment of eleven cases of Schistosomiasis japonica with CIBA 32,644-Ba. Acta Trop. Suppl. 9: 236– 243. 59 PESIGAN, T. P., T. C. BANZON & R. G. ZABALA. 1966. Treatment of Schistosomiasis japonicum with CIBA 32,644-Ba. A preliminary report. Acta Trop. Suppl. 9: 224– 235. 60 BANZON, T. C. 1966. Ambilhar (CIBA 32,644-Ba) in the oral treatment of schistosoma japonicum infection. Personal communication. 61 HESS, R., J. W. FAIGLE & C. LAMBERT. 1966. Selective uptake of an antibilharzial nitrothiazole compound by Schistosoma mansoni. Nature 210: 964– 965. 62 LAMBERT, C., H. STRIEBEL & P. STAUFFER. 1966. Le devenir et la signification des oeufs morts de Schistosoma mansoni dans la paroi intestinale de la souris. Acta Trop. 23: 137– 145. 63 KATZ, N., E. A. X. CANÇADO, & J. PELLEGRINO. 1966. Ensaios clínicos na esquistossomose mansoni com Ambilhar(R) associado a barbitúricos. Folha Med. 54: 6: 795– 804. 64 LAMBERT, C. R. 1966. Transaminases et rôle du filtre hépatique lors du traitement au CIBA 32,644-Ba. Acta Trop. Suppl. 9: 28– 34. 65 DA SILVA, J. R. 1966. CIBA 32,644-Ba and spermatogenesis in man. Preliminary results. Acta Trop. Suppl. 9: 283– 286. 66 PRATES, M. D. & L. T. A. FRANCO. 1966. Action du CIBA 32,644-Ba sur la spermatogénèse. Etude préliminaire. Acta Trop. Suppl. 9: 287– 288. 67 DOYEN, A., J. LÉONARD, S. MBENDI & J. SONNET. 1967. Influence des doses thérapeutiques du CIBA 32,644-Ba sur l'hématopoièse des patients atteints de bilharziose et d'amibiase. Acta Trop. 24: 59– 77. 68 ZACHARIAS, N., P. R. CARVALHO & J. F. PENTEADO. 1967. Tratamento da esquistossomose mansônica pela associação Ambilhar/barbitúrico. Nota prévia acêrca da tolerabilidade. Hospital 71: 657– 662. 69 DOMART & M. GENTILINI. Unpublished data. Citing Literature Volume160, Issue2The Pharmacological and Chemotherapeutic Properties of Niridazole and Other Antischistomal CompoundsOctober 1969Pages 811-820 ReferencesRelatedInformation
Referência(s)